Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Hematology, Kameda Medical Center, Chiba, Japan)
Session information
Oral Session
Oral Session 1-10D MM: Daratumumab
Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.10 (Osaka International Convention Center, 10F 1009)
Chair: Tadao Ishida (Department of Hematology,Japanese Red Cross Medical Center, Japan)
Kenshi Suzuki1, Shinsuke Iida2, Hirohiko Shibayama3, Hidehisa Noguchi4, Hiroshi Yamazaki4, Hiromi Koga4, Hiroyuki Takamatsu5 (1.Japanese Red Cross Medical center, Tokyo, Japan, 2.Hematol.&Oncol. Nagoya City University, Nagoya, Japan, 3.Osaka Univ. Grad. Schl. Med., Osaka, Japan, 4.Janssen Pharmaceutical K.K. , Tokyo, Japan, 5.Hematology/Respiratory Medicine, Kanazawa Univ., Kanazawa, Japan)
Kohei Tada, Chika Yamada, Tomohiro Taya, Hirotaka Nakamura, Ryosuke Nomura, Takaya Mitsuyoshi, Noriko Sugino, Masaharu Tashima, Hitomi Kaneko, Kazuo Hatanaka, Chisato Mizutani, Kazunori Imada (Osaka Red Cross Hospital, Department of Hematology)
Kota Sato, Tadao Ishida, Kanji Miyazaki, Yumiko Yoshiki, Yu Abe, Kiyoshi Okazuka, Nobuhiro Tsukada, Kenshi Suzuki (Japanese Red Cross Medical Center, Tokyo, Japan)
Teruhito Takakuwa, Taku Araki, Ippei Otomaru, Ayano Nishiura, Akiko Miura, Yotaro Fujitani, Ryosuke Yamamura, Kensuke Ohta (Hematology, Osaka Saiseikai Nakatsu Hospital, Japan)
Tomohiko Kamimura1, Takatoshi Aoki1, Noriko Yokota2, Nanami Hasegawa3, Daisuke Ishihara1, Takeshi Umeno1, Shingo Urata1, Toshihiro Miyamoto4, Koichi Akashi4 (1.Department of Hematology, Harasanshin Hospital, Fukuoka, Japan, 2.Department of Nursing, Harasanshin Hospital, Fukuoka, Japan, 3.Department of Pharmacy, Harasanshin Hospital, Fukuoka, Japan, 4.Department of Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital)